Everolimus [clinicaltrials_resource:0a76bae91ee02c507d1d3c4298cde75e]
condition [clinicaltrials_vocabulary:condition]
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant [clinicaltrials:NCT00005113]clinicaltrials:NCT00006178CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00016328]CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer [clinicaltrials:NCT00028028]CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00033267]Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients [clinicaltrials:NCT00037531]clinicaltrials:NCT00038948Sirolimus for Focal Segmental Glomerulosclerosis [clinicaltrials:NCT00040508]Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy [clinicaltrials:NCT00050713]Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients [clinicaltrials:NCT00062712]clinicaltrials:NCT00062751clinicaltrials:NCT00065468clinicaltrials:NCT00068302clinicaltrials:NCT00072176CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [clinicaltrials:NCT00075647]Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy [clinicaltrials:NCT00076206]clinicaltrials:NCT00076570Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond To Prior Treatment [clinicaltrials:NCT00079183]CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00079235]Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00079456]clinicaltrials:NCT00081874Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer [clinicaltrials:NCT00083993]CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [clinicaltrials:NCT00084916]clinicaltrials:NCT00085566clinicaltrials:NCT00086346CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [clinicaltrials:NCT00086840]CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor [clinicaltrials:NCT00087074]RAD001 in Recurrent Endometrial Cancer Patients [clinicaltrials:NCT00087685]Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00089037]Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate [clinicaltrials:NCT00093639]Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma [clinicaltrials:NCT00093782]Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor [clinicaltrials:NCT00095329]clinicaltrials:NCT00096486Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy [clinicaltrials:NCT00097968]A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients [clinicaltrials:NCT00098007]Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients [clinicaltrials:NCT00098241]CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00098501]clinicaltrials:NCT00098553Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00101088]Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00105001]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Everolimus [clinicaltrials_resource:0a76bae91ee02c507d1d3c4298cde75e]
Bio2RDF identifier
0a76bae91ee02c507d1d3c4298cde75e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0a76bae91ee02c507d1d3c4298cde75e
identifier
clinicaltrials_resource:0a76bae91ee02c507d1d3c4298cde75e
title
Everolimus
@en
type
label
Everolimus [clinicaltrials_resource:0a76bae91ee02c507d1d3c4298cde75e]
@en